A detailed history of Marshall Wace, LLP transactions in Immunic, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 466,287 shares of IMUX stock, worth $498,927. This represents 0.0% of its overall portfolio holdings.

Number of Shares
466,287
Previous 39,621 1076.87%
Holding current value
$498,927
Previous $43,000 1688.37%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.08 - $1.95 $460,799 - $831,998
426,666 Added 1076.87%
466,287 $769,000
Q2 2024

Aug 14, 2024

SELL
$0.98 - $1.44 $9,709 - $14,267
-9,908 Reduced 20.0%
39,621 $43,000
Q1 2024

May 15, 2024

BUY
$1.14 - $1.53 $34,485 - $46,282
30,250 Added 156.91%
49,529 $65,000
Q4 2023

Feb 14, 2024

SELL
$0.97 - $1.6 $166,427 - $274,520
-171,575 Reduced 89.9%
19,279 $28,000
Q3 2023

Nov 14, 2023

BUY
$1.35 - $2.87 $257,652 - $547,750
190,854 New
190,854 $280,000
Q1 2023

May 15, 2023

BUY
$1.35 - $2.87 $49,913 - $106,112
36,973 Added 37.93%
134,459 $200,000
Q4 2022

Feb 14, 2023

BUY
$1.13 - $10.8 $82,617 - $789,620
73,113 Added 299.98%
97,486 $136,000
Q3 2022

Nov 14, 2022

BUY
$3.0 - $5.49 $73,119 - $133,807
24,373 New
24,373 $77,000
Q1 2022

May 16, 2022

SELL
$9.54 - $14.26 $23,201 - $34,680
-2,432 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$7.34 - $10.25 $17,850 - $24,928
2,432 New
2,432 $24,000

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $32.7M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.